Your patient presents with brain fog, fatigue, joint pain, and hair loss. You run comprehensive labs. Most results look relatively normal or inconclusive. You refer to specialists. They find nothing definitive.

So she gets labeled: anxiety, fibromyalgia, chronic fatigue syndrome or early menopause. She's prescribed antidepressants, hormone therapy, and anti-inflammatory protocols.

Her improvement is transient, if at all, and her underlying condition remains unaddressed.

She's been to multiple practitioners. She's tried detox protocols, supplement regimens, lifestyle changes. She improves temporarily, then plateaus or regresses. New symptoms emerge. Or old ones creep back with a vengeance.

The problem: You're treating downstream effects while the inflammatory source persists.

Most practitioners have not been trained to recognize breast implant illness. They don't ask about implants. They don't connect the constellation of symptoms. They don't understand that both saline and silicone implants pose immune risks—because the shell, not the fill, is what matters.

And so your patients remain undiagnosed. Misdiagnosed. Trapped in a cycle of treatments that address symptoms but never the cause.

The clinical depth you need to recognize and help these patients has never been systematized or taught. Until now.